Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Clinically proven to visibly reduce discoloration and help prevent future pigment formation, the new serum marks a major advancement in biotech skincare innovation. Powered by patented MI9™ peptide, ...
Will leverage PolyPeptide’s peptide manufacturing and development services and Lifecore’s formulation, fill/finish, and packaging services.
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global ...
Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...
Arch Biopartners (($TSE:ARCH)) announced an update on their ongoing clinical study. Arch Biopartners is conducting a Phase 2 global study titled ...
TipRanks on MSN
Pangea’s Amino Innovations Partners with University of Alberta for Peptide Advancements
The latest update is out from Pangea Natural Food, Inc. ( (TSE:PNGA) ).
Pangea Natural Foods Inc. (CSE:PNGA) (OTC: PNGAF) (" Pangea " or the " Company"), is excited to announce that its wholly ...
Durham, North Carolina, October 20th, 2025, FinanceWireMicropep Technologies, an agtech company specializing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback